Trial reportLasers in medical science2026
Facial contour modulation and skin tightening using 40.68-MHz unipolar radiofrequency.
Trial report in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate changes in facial contour and skin elasticity following full-face treatment with 40.68-MHz unipolar radiofrequency (RF), and to assess its safety and tolerability in adults with mild-to-moderate facial laxity. This prospective single-arm interventional clinical study evaluated adults with mild-to-moderate facial laxity who underwent three full-face 40.68-MHz unipolar RF treatment sessions at 4-week intervals. The primary endpoint was the change in VECTRA-derived three-dimensional facial volumetric parameters from baseline to Week 20. Secondary outcomes included Cutometer-derived skin elasticity parameters (R2 and R5), Global Aesthetic Improvement Scale (GAIS), FACE-Q satisfaction scores, visual analog scale (VAS) pain scores, and adverse event monitoring. Of the 30 enrolled participants, 26 completed follow-up and were included in the final analysis. By Week 20, VECTRA 3D analysis demonstrated modest volume reductions in the cheek (- 2.2 mL), jowl (- 1.7 mL), and submental region (- 2.9 mL). Skin elasticity parameters increased over time, with R2 increasing from 0.62 to 0.69 and R5 from 0.53 to 0.59. GAIS improvement was observed in 88.5% of participants, and the mean FACE-Q score increased to 72.4 ± 10.1. Treatment was well tolerated, with low mean pain scores (VAS 1.2 ± 0.9). Only transient erythema and mild edema were reported, with no serious adverse events observed. Three sessions of 40.68-MHz unipolar RF were associated with modest measurable improvements in facial contour and skin elasticity that were maintained during the 20-week observation period, with good tolerability and no serious adverse events. Because this was an uncontrolled single-arm study, these findings should be interpreted as preliminary and require confirmation in controlled studies with longer follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.